Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q2 2019 · 10-Q
Revenue$86.00K$86.00K−64.0% vs Q2 2018 Net Income-$3.75M-$3.75MN/M vs Q2 2018 EPS Diluted-$0.77-$0.77N/M vs Q2 2018 Operating Income-$3,762,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,321,000N/M Margins · derivedOperating margin-4374.4%−3013.7 pt vs Q2 2018
Net margin-4360.5%−3014.4 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end